Theracryf (TCF)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.25p
   
  • Change Today:
      0.010p
  • 52 Week High: 1.22p
  • 52 Week Low: 0.20p
  • Currency: UK Pounds
  • Shares Issued: 2,148.96m
  • Volume: 10,785,074
  • Market Cap: £5.26m
  • Beta: 0.00

Deal with Barclays    Trade now with Barclays Stockbrokers

Broker Views

Show broker recommendations:
Show broker actions:
Date Broker name New Price Old price target New price target Broker change
11-Sep-18 Northland Capital Partners Buy 15.75p - 113.00p Reiteration
27-Jul-18 Northland Capital Partners Buy 17.00p - 113.00p Reiteration
11-Jun-18 Northland Capital Partners Buy 22.10p - 113.00p Reiteration
04-May-18 Northland Capital Partners Buy 19.00p 113.00p 113.00p Reiteration
05-Mar-18 Northland Capital Partners Corporate 14.75p - - Reiteration
04-Jan-16 Northland Capital Partners Buy 23.25p - 79.00p Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

Theracryf Market Data

Currency UK Pounds
Share Price 0.25p
Change Today 0.010p
% Change 4.26 %
52 Week High 1.22p
52 Week Low 0.20p
Volume 10,785,074
Shares Issued 2,148.96m
Market Cap £5.26m
Beta 0.00

Theracryf Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
43.95% below the market average43.95% below the market average43.95% below the market average43.95% below the market average43.95% below the market average
53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average
Price Trend
94.73% below the market average94.73% below the market average94.73% below the market average94.73% below the market average94.73% below the market average
82.98% below the sector average82.98% below the sector average82.98% below the sector average82.98% below the sector average82.98% below the sector average
Income Not Available
Growth
16.63% below the market average16.63% below the market average16.63% below the market average16.63% below the market average16.63% below the market average
29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average

Theracryf Dividends

No dividends found

Trades for 23-May-2025

Time Volume / Share Price
13:30 1,000,000 @ 0.26p
12:21 2,000,000 @ 0.26p
12:20 467 @ 0.27p
12:20 1,000 @ 0.22p
12:20 250 @ 0.27p

Theracryf Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page